ETAO Price to Sales Ratio 2022-2023 | ETAOF
Historical PS ratio values for ETAO (ETAOF) over the last 10 years. The current P/S ratio for ETAO as of May 31, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| ETAO P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-05-08 | 1.91 | inf | |
| 2023-06-30 | 0.66 | 0 | 0.00 |
| 2022-12-31 | 10.13 | 0 | 0.00 |
| 2022-09-30 | 9.95 | 0 | 0.00 |
| 2022-06-30 | 9.89 | 0 | 0.00 |
| 2022-03-31 | 9.89 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.002B | $0.058B |
| ETAO International Group is a digital healthcare group providing medical care using biomedical and AI technologies to patients principally in China. ETAO International Group, formerly known as Mountain Crest Acquisition Corp. III, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.604B | 19.55 |
| Inspire Medical Systems (INSP) | United States | $4.718B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.171B | 0.00 |
| Axonics (AXNX) | United States | $3.423B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.978B | 0.00 |
| Enovis (ENOV) | United States | $2.757B | 20.43 |
| IRhythm Technologies (IRTC) | United States | $2.744B | 0.00 |
| Azenta (AZTA) | United States | $2.722B | 153.06 |
| 10x Genomics (TXG) | United States | $2.672B | 0.00 |
| Privia Health (PRVA) | United States | $2.073B | 115.80 |
| Schrodinger (SDGR) | United States | $1.564B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 51.73 |
| Phreesia (PHR) | United States | $1.084B | 0.00 |
| Standard BioTools (LAB) | United States | $0.917B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.627B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.546B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.391B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.210B | 0.00 |
| Outset Medical (OM) | United States | $0.193B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.159B | 0.00 |
| TruBridge (TBRG) | United States | $0.141B | 7.59 |
| American Well (AMWL) | United States | $0.127B | 0.00 |
| 111 (YI) | China | $0.101B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.100B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.081B | 0.00 |
| HeartBeam (BEAT) | United States | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.062B | 0.00 |
| Zepp Health (ZEPP) | China | $0.046B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.045B | 0.00 |
| Augmedix (AUGX) | United States | $0.045B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.038B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Cue Health (HLTH) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |